Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
M Ventures
AddedFeb 17, 2024
UpdatedJun 28, 2026
M Ventures

M Ventures

Operating

Merck Ventures BV: A global venture capital firm specializing in healthcare, life science, and startups.

Location
Amsterdam, North Holland, NL
Founded
2014
Firm
Compare
Portfolio
Employees

Investments

Polaris Electro-Optics
Polaris Electro-Optics

Total Raised

$3M

Rounds

1

Seed$3MDecember 2023
CellFE
CellFE

Total Raised

$26.8M

Rounds

3

Series A$22MSeptember 2023
Celestial AI
Celestial AI

Total Raised

$163.9M

Rounds

4

Series B$100MJune 2023
Series A$56MFebruary 2022
ImmuneBridge
ImmuneBridge

Total Raised

$12M

Rounds

4

Seed$12MJanuary 2023
Sonde Health
Sonde Health

Total Raised

$41.3M

Rounds

4

Series B$19.3MDecember 2022
Series A$16MApril 2019
Oxford Sciences Innovation
Oxford Sciences Innovation

Total Raised

$319.8M

Rounds

5

Series A$37.5MOctober 2022
Metalenz
Metalenz

Total Raised

$47.4M

Rounds

4

Series B$30MOctober 2022
Series A$10MFebruary 2021
Pictor Labs
Pictor Labs

Total Raised

$18.8M

Rounds

2

Series A$15.2MMay 2022
Concerto Biosciences
Concerto Biosciences

Total Raised

$26M

Rounds

2

Series A$24.5MMarch 2022
Plexium
Plexium

Total Raised

$165M

Rounds

6

Series B$102MFebruary 2022
Biolinq
Biolinq

Total Raised

$196.3M

Rounds

8

Series B$100MNovember 2021
Series A$4.8MMarch 2019
Immunitas Therapeutics
Immunitas Therapeutics

Total Raised

$97M

Rounds

2

Series B$58MAugust 2021
Soteria Biotherapeutics
Soteria Biotherapeutics

Total Raised

$42M

Rounds

1

Series A$42MMay 2021
Medisafe
Medisafe

Total Raised

$51.5M

Rounds

5

Series C$30MFebruary 2021
Tipe
Tipe
Seed

Total Raised

$2.2M

Rounds

2

Seed$2.1MSeptember 2020
Neurable
Neurable
Series A

Total Raised

$9.8M

Rounds

12

Series A$6MDecember 2019
Simulate
Simulate

Total Raised

$57M

Rounds

2

Seed$7MJuly 2019
Ribometrix
Ribometrix

Total Raised

$45.3M

Rounds

3

Series A$30MNovember 2018
Safari AI
Safari AI

Total Raised

$8M

Rounds

1

Seed$8MNovember 2018
ApoGen Biotechnologies
ApoGen Biotechnologies

Total Raised

$11M

Rounds

3

Series A$4MAugust 2018
Vantage Point
Vantage Point

Total Raised

$4.4M

Rounds

4

Pre-Seed$1.4MAugust 2018